Cite
HARVARD Citation
Xavier-Ferrucio, J. et al. (n.d.). P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT.. HemaSphere. pp. 1312-1313. [Online].